• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 15-12G filed by Good Works II Acquisition Corp.

    3/28/23 4:00:03 PM ET
    $GWII
    Consumer Electronics/Appliances
    Industrials
    Get the next $GWII alert in real time by email
    15-12G 1 ea175846-1512g_goodworks2.htm FORM 15-12G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 15

     

    CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

     

    Commission File Number: 001-40585

     

    GOOD WORKS II ACQUISITION CORP.

    (Exact name of registrant as specified in its charter)

     

    4265 SAN FELIPE, SUITE 603

    HOUSTON, texas 77027

    (713) 468-2717

    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

     

    Common Stock, Par Value $0.0001 Per Share

    Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per whole share

    (Title of each class of securities covered by this Form)

     

    None

    (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

     

    Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

     

    Rule 12g-4(a)(1) ☒
    Rule 12g-4(a)(2) ☐
    Rule 12h-3(b)(1)(i) ☒
    Rule 12h-3(b)(1)(ii) ☐
    Rule 15d-6 ☐
    Rule 15d-22(b) ☐

     

    Approximate number of holders of record as of the certification or notice date: Seven

     

     

     

     

     

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, Good Works II Acquisition Corp. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

     

    Date: March 28, 2023Good Works II ACQUISITION CORP.
        
     By: /s/ Cary Grossman
     Name:  Cary Grossman
     Title: President & Chief Executive Officer

     

     

     

     

    Get the next $GWII alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GWII

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GWII
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Good Works II Acquisition Corp. and Direct Biologics, LLC Announce a Definitive Agreement for a Business Combination

    Good Works II Acquisition Corp. (NASDAQ:GWII) ("Good Works II"), a publicly traded special purpose acquisition company ("SPAC"), and Direct Biologics, LLC ("Direct Biologics"), a late-stage biotechnology company, today announced the signing of a definitive agreement that, upon the satisfaction of all closing conditions, will result in Direct Biologics becoming a publicly traded company. Upon transaction close, which is expected to occur in the first half of 2023, the combined company will be named Direct Biologics, Inc. and shares of its common stock are expected to trade on the Nasdaq Capital Market. Cary Grossman, Chief Executive Officer of Good Works II, commented, "We formed Good Works

    10/13/22 8:00:00 AM ET
    $GWII
    Consumer Electronics/Appliances
    Industrials

    Good Works II Acquisition Corp. Announces Letter of Intent for a Business Combination with Direct Biologics, LLC

    Direct Biologics leverages a proprietary extracellular vesicle platform technology designed to harness the power of bone marrow-derived mesenchymal stem cells to develop cell-free therapeutics Product candidate, ExoFlo™, is in a Phase 3 clinical trial for treating moderate-to-severe acute respiratory distress syndrome in hospitalized adults with severe-to-critical COVID-19 Proposed transaction values Direct Biologics at an enterprise value of $675 million Good Works II Acquisition Corp. (NASDAQ:GWII) ("Good Works II"), a publicly traded special purpose acquisition company ("SPAC"), and Direct Biologics, LLC ("Direct Biologics"), a late-stage biotechnology company, today announced the sig

    9/27/22 8:00:00 AM ET
    $GWII
    Consumer Electronics/Appliances
    Industrials

    $GWII
    SEC Filings

    View All

    SEC Form 15-12G filed by Good Works II Acquisition Corp.

    15-12G - Good Works II Acquisition Corp. (0001850487) (Filer)

    3/28/23 4:00:03 PM ET
    $GWII
    Consumer Electronics/Appliances
    Industrials

    SEC Form 25-NSE filed by Good Works II Acquisition Corp.

    25-NSE - Good Works II Acquisition Corp. (0001850487) (Subject)

    3/15/23 4:22:51 PM ET
    $GWII
    Consumer Electronics/Appliances
    Industrials

    Good Works II Acquisition Corp. filed SEC Form 8-K: Other Events

    8-K - Good Works II Acquisition Corp. (0001850487) (Filer)

    2/22/23 8:00:42 AM ET
    $GWII
    Consumer Electronics/Appliances
    Industrials

    $GWII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Zeidman Fred S gifted 50,000 shares, decreasing direct ownership by 12% to 350,000 units

    4 - Good Works II Acquisition Corp. (0001850487) (Issuer)

    7/12/22 5:00:12 PM ET
    $GWII
    Consumer Electronics/Appliances
    Industrials

    SEC Form 4: Wurth Douglas Clark gifted 50,000 shares, decreasing direct ownership by 12% to 350,000 units

    4 - Good Works II Acquisition Corp. (0001850487) (Issuer)

    7/12/22 5:00:14 PM ET
    $GWII
    Consumer Electronics/Appliances
    Industrials

    SEC Form 4: Grossman Cary M received a gift of 60,000 shares, increasing direct ownership by 15% to 460,000 units

    4 - Good Works II Acquisition Corp. (0001850487) (Issuer)

    7/12/22 5:00:09 PM ET
    $GWII
    Consumer Electronics/Appliances
    Industrials

    $GWII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Good Works II Acquisition Corp.

    SC 13G - Good Works II Acquisition Corp. (0001850487) (Subject)

    2/14/23 2:44:10 PM ET
    $GWII
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G/A filed by Good Works II Acquisition Corp. (Amendment)

    SC 13G/A - Good Works II Acquisition Corp. (0001850487) (Subject)

    2/13/23 4:08:55 PM ET
    $GWII
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G/A filed by Good Works II Acquisition Corp. (Amendment)

    SC 13G/A - Good Works II Acquisition Corp. (0001850487) (Subject)

    1/30/23 2:23:20 PM ET
    $GWII
    Consumer Electronics/Appliances
    Industrials